NCT04403360

Brief Summary

Lumbar spinae stenosis surgery is a frequent intervention resulting in important postoperative pain. Management of this postoperative pain is thus important. Different pain management therapies exist. The erector spinae plane (ESP) block was described in 2016. It involves the injection of local anesthetics into the interfascial plane, deep to erector spinae muscle, allowing the blockade of the dorsal and ventral rami of the thoracic spinal nerves. It was initially proposed for analgesia of costal fractures, pulmonary lobectomy and thoracic vertebrae. The ESP block (ESPB) could probably be extended to a large number of surgical procedures. ESPB has so far not been investigated in lumbar spinae stenosis surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 27, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

May 27, 2020

Status Verified

May 1, 2020

Enrollment Period

2.3 years

First QC Date

May 21, 2020

Last Update Submit

May 21, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total 24 h Piritramide consumption

    Total consumption of Piritramide consumption after surgery

    24 hours

Secondary Outcomes (1)

  • Quebec back pain disability scale (QBPDS)

    At 2 months]

Study Arms (2)

Erector Spinae plane Block (ESPB) group

EXPERIMENTAL

The ultrasound-guided ESPB was realized at T12 level (levo bupivacaine 0.25% + epinephrine 1:200.000 4mg.kg-1 body weight)after the induction of anesthesia but before the start of the surgery.

Procedure: ESPB

Local anesthesia infiltration by the surgeon

ACTIVE COMPARATOR

The surgeon infiltrates the surgical site after skin incision with local anesthetics (Levo Bupivacaïne 0.25% + epinephrine 1:200.000 4mg.kg-1 body weight)

Procedure: Local infiltration by the surgeon

Interventions

ESPBPROCEDURE

Ultrasound guided performance of ESPB at T12 level after the induction of anesthesia but before the start of the surgery

Erector Spinae plane Block (ESPB) group

Local infiltration of anesthetics at surgical site after skin incision

Local anesthesia infiltration by the surgeon

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Any lumbar spinae surgery on 2 or more lumbar levels

You may not qualify if:

  • Contraindication to NSAID
  • Allergy to any local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Saint Pierre

Ottignies, Brabant Wallon, 1340, Belgium

RECRUITING

Related Publications (1)

  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.

MeSH Terms

Conditions

Spinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Georges SAMOURI, MD

    Clinique Saint Pierre Ottignies

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Georges SAMOURI, MD

CONTACT

Nicolas PARISI, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Georges Samouri M.D.

Study Record Dates

First Submitted

May 21, 2020

First Posted

May 27, 2020

Study Start

October 1, 2018

Primary Completion

December 31, 2020

Study Completion

April 1, 2021

Last Updated

May 27, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

All data will be presented in future manuscripts.

Locations